Compremium

Executive Summary

Compremium is a Swiss medtech company that has developed an AI-powered device, Quantis ST, to provide objective, non-invasive measurements of soft tissue compressibility. Traditional assessment of tissue edema and swelling in orthopaedic trauma is subjective and inconsistent. Quantis ST addresses this gap by using machine learning to standardize tissue palpation, enabling clinicians to track recovery and make data-driven decisions. The device is both CE-marked and FDA-cleared, giving it regulatory access to European and U.S. markets. Founded in 2018 and based in Basel, the company is well-positioned to address an unmet need in postoperative monitoring, with potential applications in lymphedema and sports medicine.

Upcoming Catalysts (preview)

• Q3 2026Commercial launch and reimbursement expansion in the U.S.75% success
• Q4 2026Publication of pivotal clinical study results in orthopaedic trauma80% success
• Q2 2027Strategic partnership with a major orthopaedic device manufacturer60% success